According to Italian legislation, any Marketing Authorisation Holder or pharmaceutical company responsible for the commercialisation of a drug, which organises or helps to organise, whether by direct or indirect funding in Italy or abroad, a congress, or a meeting on topics in any way related to the use of medicines, shall notify the competent Unit of the Italian Medicines Agency (AIFA) at least 60 days before the date of the event to ensure that these adhere to strict technical criteria and aim to provide further knowledge in the fields of chemistry, pharmaceutical technology, biochemistry, physiology, pathology and clinical medicine.
OIC S.r.l. has been appointed as the official agency for AIFA submission to support sponsors and exhibitors with these formalities. Pharmaceutical companies which require the authorisation from AIFA are advised to contact:Italian Agency for AIFA ProceduresOIC S.r.l. Ms. Gabriela de FeoVia Matteotti 750121 Firenze - ItalyTel. +39 055 50 351FAX +39 055 570 227e-mail: firstname.lastname@example.org
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved